Oxford Uni vaccine appears safe and trains body immune system, early trials reveal

    0
    72
    OXFORD, ENGLAND - JUNE 24: A scientist at work during a visit by Prince William, The Duke of Cambridge to the manufacturing laboratory where a vaccine against COVID-19 has been produced at the Oxford Vaccine Group's facility at the Churchill Hospital on June 24, 2020 in Oxford, England. Trials began on 23rd April, with ten thousand people across the UK in the process of being vaccinated in the latest study to assess the potential success of the treatment, with the UK Government providing ??84 million for the University of Oxford to develop and manufacture its coronavirus vaccine. (Photo by Steve Parsons - WPA Pool/Getty Images)

    Revealed: The Secrets our Clients Used to Earn $3 Billion

    A researcher at work in the production lab where a vaccine versus COVID-19 has actually been produced at the Oxford Vaccine Group’s center (Picture; Getty)

    The Covid-19 vaccine being established at the University of Oxford is safe and causes an immune response, findings of the very first stages of the research study recommend.

    The findings on the Oxford vaccine trial were released in medical journal, The Lancet.

    Professor Sarah Gilbert, of the University of Oxford, stated: ‘There is still much work to be done prior to we can validate if our vaccine will assist handle the Covid-19 pandemic, however these early outcomes hold guarantee.

    ‘As well as continuing to evaluate our vaccine in phase-three trials, we require to get more information about the infection – for instance, we still do not understand how strong an immune reaction we require to provoke to efficiently secure versus Sars-Cov-2 infection.

    “If our vaccine works, it is an appealing choice as these kinds of vaccine can be produced at big scale.

    Visit our live blog site for the current updates: Coronavirus news live

    ‘A successful vaccine against Sars-Cov-2 could be used to prevent infection, disease and death in the whole population, with high-risk populations such as hospital workers and older adults prioritised to receive vaccination.’

    In this screen grab from video issued by Britain's Oxford University, a volunteer is injected with either an experimental COVID-19 vaccine or a comparison shot as part of the first human trials in the U.K. to test a potential vaccine, led by Oxford University in England on April 25, 2020. About 100 research groups around the world are pursuing vaccines against the coronavirus, with nearly a dozen in early stages of human trials or poised to start. (University of Oxford via AP)

    A volunteer is injected with either a speculative COVID-19 vaccine or a contrast shot as part of the very first human trials in the UK to evaluate a possible vaccine, led by Oxford University (Picture: AP)

    Health Secretary Matt Hancock stated the upgrade on the vaccine was ‘very encouraging news’.

    He tweeted: ‘We have actually currently purchased 100 million dosages of this vaccine, must it prosper.

    ‘Congratulations to the scientists at @UniofOxford & @OxfordVacGroup and leadership of @AstraZeneca.’

    Boris Johnson tweeted: ‘This is extremely favorable news. A substantial well done to our dazzling, world-leading researchers & scientists at @UniofOxford.

    ‘There are no guarantees, we’re not there yet & even more trials will be essential – however this is an essential action in the ideal instructions.’

    Get in touch with our news group by emailing us at webnews@metro.co.uk.

    For more stories like this, inspect our news page.



    This site uses Akismet to reduce spam. Learn how your comment data is processed.